Table 3

Fold changes in inflammatory gene expression in MNC and plasma IL-6 at 2 and 6 hours in FDRT (n=9) and non-FDRT (n=9) subjects after a meal challenge

Δ 2 hoursΔ 6 hoursGroupTimeGroup×time
Proinflammatory genesTNFαFDRT1.36±0.101.80±0.160.0010.0010.007
Non-FDRT1.06±0.081.17±0.07
IL-6FDRT1.33±0.566.73±2.380.0890.0020.153
Non-FDRT0.56±0.162.68±0.89
MCP-1FDRT0.99±0.205.16±2.060.1160.0050.159
Non-FDRT0.61±0.092.00±0.37
TLR4FDRT1.03±0.081.34±0.120.3970.0010.417
Non-FDRT1.02±0.071.19±0.06
IL-1βFDRT0.91±0.081.30±0.200.9160.0080.817
Non-FDRT0.96±0.071.22±0.08
NF-κB/p105FDRT1.00±0.071.11±0.060.2090.7410.106
Non-FDRT0.99±0.050.93±0.07
Rel-AFDRT1.00±0.051.39±0.150.1120.0010.220
Non-FDRT0.90±0.061.13±0.07
Anti-inflammatory genesIκB-βFDRT1.00±0.091.64±0.290.1370.0010.355
Non-FDRT0.89±0.041.26±0.11
IκB-αFDRT0.89±0.031.03±0.050.7810.0050.254
Non-FDRT0.92±0.050.97±0.04
IL-10FDRT1.54±0.338.94±3.430.0570.0040.077
Non-FDRT0.72±0.192.57±0.67
TGFβFDRT1.04±0.041.09±0.070.1140.0040.114
Non-FDRT1.24±0.121.31±0.13
CytokineIL-6
(plasma)
FDRT0.64±0.161.02±0.130.3490.0010.606
Non-FDRT0.43±0.100.98±0.18
  • Data are mean±SEM. P<0.05 using a linear mixed model. Numbers in bold represent significant values.

  • FDRT, first-degree relative with type 2 diabetes mellitus; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; MNC, mononuclear cell; NF-κB, nuclear factor kappa B; TGFβ, transforming growth factor-β; TLR4, Toll-like receptor 4; TNFα, tumor necrosis factor alpha.